Eli Lilly's Foundayo Shows Promising Results Against Diabetes and Heart Disease Risks #United_States #Indianapolis #Eli_Lilly #Type_2_Diabetes #Foundayo
@newsen.bsky.social
@newsen.bsky.socialEli Lilly's Foundayo Shows Promising Results Against Diabetes and Heart Disease Risks #United_States #Indianapolis #Eli_Lilly #Type_2_Diabetes #Foundayo
@newsen.bsky.socialLilly's Foundayo Shows Promise for Diabetes Management with Cardiovascular Benefits #United_States #Indianapolis #Diabetes_Care #Eli_Lilly #Foundayo
@newsen.bsky.socialEli Lilly's Foundayo Outperforms Semaglutide in Weight Loss and A1C Reduction #USA #Indianapolis #Semaglutide #Eli_Lilly #Foundayo
@newsen.bsky.socialLilly Unveils Ambitious Commitment to Close Diabetes Treatment Gaps in Low-Income Countries #United_States #Indianapolis #Lilly #diabetes #Foundayo
@hqcook.bsky.socialMartha Stewart “likes rules”?!?
She went to prison! Who approved this ad? #foundayo
@4040rec.bsky.social
@newsanalysis.com@newsen.bsky.socialEli Lilly Begins Construction of New Houston Manufacturing Site to Boost Domestic Pharmaceutical Production #United_States #Houston #Eli_Lilly #Foundayo
@newsen.bsky.socialEli Lilly Unveils Revolutionary Cardiometabolic Health Data at EASD 2026 #USA #Indianapolis #Eli_Lilly #retatrutide #Foundayo
@sustainhealth.bsky.socialTHE IMPORTANT DIFFERENCE IS NOT JUST THE PILL
Foundayo gives patients an oral GLP-1 option, but it is not Mounjaro in tablet form. The real significance is broader choice — particularly for people reluctant to self-inject.